• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活体供肝移植早期干预可降低非酒精性脂肪性肝炎的资源利用:多伦多经验

Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto Experience.

作者信息

Barbas Andrew S, Goldaracena Nicolas, Dib Martin J, Al-Adra David P, Aravinthan Aloysious D, Lilly Leslie B, Renner Eberhard L, Selzner Nazia, Bhat Mamatha, Cattral Mark S, Ghanekar Anand, McGilvray Ian D, Sapisochin Gonzalo, Selzner Markus, Greig Paul D, Grant David R

机构信息

Multi-Organ Transplant Program, University of Toronto, Toronto, ON, Canada.

出版信息

Transplant Direct. 2017 May 10;3(6):e158. doi: 10.1097/TXD.0000000000000674. eCollection 2017 Jun.

DOI:10.1097/TXD.0000000000000674
PMID:28620642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5464777/
Abstract

BACKGROUND

In parallel with the obesity epidemic, liver transplantation for nonalcoholic steatohepatitis (NASH) is increasing dramatically in North America. Although survival outcomes are similar to other etiologies, liver transplantation in the NASH population has been associated with significantly increased resource utilization. We sought to compare outcomes between live donor liver transplantation (LDLT) and deceased donor liver transplantation (DDLT) at a high volume North American transplant center, with a particular focus on resource utilization.

METHODS

The study population consists of primary liver transplants performed for NASH at Toronto General Hospital from 2000 to 2014. Recipient characteristics, perioperative outcomes, graft and patient survivals, and resource utilization were compared for LDLT versus DDLT.

RESULTS

A total of 176 patients were included in the study (48 LDLT vs 128 DDLT). LDLT recipients had a lower model for end-stage liver disease score and were less frequently hospitalized prior to transplant. Estimated blood loss and early markers of graft injury were lower for LDLT. LDLT recipients had a significantly shorter hospitalization (intensive care unit, postoperative, and total hospitalization).

CONCLUSIONS

LDLT for NASH facilitates transplantation of patients at a less severe stage of disease, which appears to promote a faster postoperative recovery with less resource utilization.

摘要

背景

随着肥胖症的流行,北美地区非酒精性脂肪性肝炎(NASH)患者的肝移植数量急剧增加。尽管NASH患者肝移植后的生存结果与其他病因的患者相似,但该群体的肝移植资源利用率显著增加。我们试图在北美一家大型移植中心比较活体供肝肝移植(LDLT)和尸体供肝肝移植(DDLT)的结果,特别关注资源利用情况。

方法

研究人群包括2000年至2014年在多伦多综合医院因NASH接受的初次肝移植患者。比较LDLT和DDLT患者的受者特征、围手术期结果、移植物和患者生存率以及资源利用情况。

结果

共有176例患者纳入研究(48例LDLT和128例DDLT)。LDLT受者的终末期肝病模型评分较低,移植前住院频率较低。LDLT的估计失血量和移植物损伤早期标志物较低。LDLT受者的住院时间(重症监护病房、术后和总住院时间)显著缩短。

结论

NASH患者接受LDLT可使病情较轻阶段的患者接受移植,这似乎能促进术后更快恢复,同时减少资源利用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f83/5464777/7444c521b065/txd-3-e158-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f83/5464777/e03c6da41acd/txd-3-e158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f83/5464777/36cdd96dda8a/txd-3-e158-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f83/5464777/7444c521b065/txd-3-e158-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f83/5464777/e03c6da41acd/txd-3-e158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f83/5464777/36cdd96dda8a/txd-3-e158-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f83/5464777/7444c521b065/txd-3-e158-g008.jpg

相似文献

1
Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto Experience.活体供肝移植早期干预可降低非酒精性脂肪性肝炎的资源利用:多伦多经验
Transplant Direct. 2017 May 10;3(6):e158. doi: 10.1097/TXD.0000000000000674. eCollection 2017 Jun.
2
Adult Living Donor Versus Deceased Donor Liver Transplant (LDLT Versus DDLT) at a Single Center: Time to Change Our Paradigm for Liver Transplant.单中心成人活体供肝与尸体供肝肝移植(LDLT 与 DDLT):是时候改变我们的肝移植模式了。
Ann Surg. 2019 Sep;270(3):444-451. doi: 10.1097/SLA.0000000000003463.
3
Impact of living donor liver transplantation on long-term cardiometabolic and graft outcomes in cirrhosis due to nonalcoholic steatohepatitis.非酒精性脂肪性肝炎相关肝硬化患者中行活体肝移植对长期心代谢及移植物结局的影响。
Clin Transplant. 2023 Sep;37(9):e15008. doi: 10.1111/ctr.15008. Epub 2023 May 4.
4
Should We Exclude Live Donor Liver Transplantation for Liver Transplant Recipients Requiring Mechanical Ventilation and Intensive Care Unit Care?对于需要机械通气和重症监护病房护理的肝移植受者,我们应该排除活体供肝肝移植吗?
Transplant Direct. 2015 Sep 22;1(8):e30. doi: 10.1097/TXD.0000000000000543. eCollection 2015 Sep.
5
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.丙型肝炎病毒感染的活体供肝与尸体供肝肝移植受者的结局
Liver Transpl. 2007 Jan;13(1):122-9. doi: 10.1002/lt.20995.
6
Defining long-term outcomes with living donor liver transplantation in North America.界定北美活体供肝移植的长期预后。
Ann Surg. 2015 Sep;262(3):465-75; discussion 473-5. doi: 10.1097/SLA.0000000000001383.
7
Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.活体供肝与死体供肝肝移植:受者发病率和结局的外科医生匹配比较。
Transpl Int. 2013 Aug;26(8):780-7. doi: 10.1111/tri.12127. Epub 2013 Jun 7.
8
Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis.成人活体供肝肝移植和尸体供肝肝移植的手术结果:一项系统评价和荟萃分析。
Liver Transpl. 2014 Apr;20(4):425-36. doi: 10.1002/lt.23836.
9
Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.与接受 deceased donor 移植的匹配队列相比,成人活体供肝移植后的移植物和患者生存率。 (注:这里“deceased donor”直译为“已故供体”,结合医学语境,通常指脑死亡后器官捐献的供体,国内一般称为“尸体供肝”,但按照任务要求未添加注释说明)
Liver Transpl. 2004 Oct;10(10):1263-8. doi: 10.1002/lt.20254.
10
Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.比较尸肝和活体肝移植后丙型肝炎复发和纤维化进展:8 年纵向随访。
Transplantation. 2011 Aug 27;92(4):453-60. doi: 10.1097/TP.0b013e3182259282.

引用本文的文献

1
Comparison of Vascular Complications Between Living-donor and Deceased-donor Liver Transplantation - A Systematic Review and Meta-analysis.活体供肝与尸体供肝肝移植血管并发症的比较——一项系统评价与Meta分析
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102414. doi: 10.1016/j.jceh.2024.102414. Epub 2024 Sep 20.
2
Comparison of Biliary Complications Between Living and Deceased Donor Liver Transplantations: A Systematic Review and Meta-analysis.活体与尸体供肝肝移植术后胆道并发症的比较:一项系统评价与Meta分析
Cureus. 2024 Sep 9;16(9):e69019. doi: 10.7759/cureus.69019. eCollection 2024 Sep.
3
The Trends in Health Care Utilization and Costs Associated With Primary Liver Cancer: An Analysis of United States Hospitals Between 2016 and 2019.

本文引用的文献

1
Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults.成人非酒精性脂肪性肝病的进展和自然史。
Clin Liver Dis. 2016 May;20(2):313-24. doi: 10.1016/j.cld.2015.10.010. Epub 2015 Dec 24.
2
Non-alcoholic fatty liver disease following liver transplantation: a clinical review.肝移植后非酒精性脂肪性肝病:临床综述
Clin Transplant. 2015 Sep;29(9):728-37. doi: 10.1111/ctr.12585. Epub 2015 Aug 11.
3
"Weighing the risk": Obesity and outcomes following liver transplantation.“权衡风险”:肥胖与肝移植后的预后
原发性肝癌的医疗利用和费用趋势:2016 年至 2019 年美国医院的分析。
J Clin Gastroenterol. 2024 Aug 1;58(7):726-736. doi: 10.1097/MCG.0000000000001927.
4
The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review.非酒精性脂肪性肝炎的经济负担:系统评价。
Pharmacoeconomics. 2022 Aug;40(8):751-776. doi: 10.1007/s40273-022-01140-y. Epub 2022 Jul 5.
5
Meta-analysis and meta-regression of outcomes for adult living donor liver transplantation versus deceased donor liver transplantation.成人活体供肝移植与尸体供肝移植结局的荟萃分析和荟萃回归。
Am J Transplant. 2021 Jul;21(7):2399-2412. doi: 10.1111/ajt.16440. Epub 2021 Jan 5.
6
Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges.肝移植治疗非酒精性脂肪性肝炎:复发的病理生理学和临床挑战。
Dig Dis Sci. 2019 Dec;64(12):3413-3430. doi: 10.1007/s10620-019-05716-1. Epub 2019 Jul 16.
World J Hepatol. 2015 Jun 18;7(11):1484-93. doi: 10.4254/wjh.v7.i11.1484.
4
Nonalcoholic fatty liver disease: a systematic review.非酒精性脂肪性肝病:系统评价。
JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370.
5
Live donor liver transplantation: a valid alternative for critically ill patients suffering from acute liver failure.活体供肝肝移植:急性肝衰竭重症患者的有效治疗选择。
Am J Transplant. 2015 Jun;15(6):1591-7. doi: 10.1111/ajt.13203. Epub 2015 Mar 19.
6
Effect of pretransplant diabetes on short-term outcomes after liver transplantation: a national cohort study.移植前糖尿病对肝移植后短期结局的影响:一项全国队列研究。
Liver Int. 2015 Jul;35(7):1902-9. doi: 10.1111/liv.12770. Epub 2015 Jan 21.
7
Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.非酒精性脂肪性肝炎是美国等待肝移植的成年人中导致肝病的第二大病因。
Gastroenterology. 2015 Mar;148(3):547-55. doi: 10.1053/j.gastro.2014.11.039. Epub 2014 Nov 25.
8
Liver transplantation and non-alcoholic fatty liver disease.肝移植与非酒精性脂肪性肝病
World J Gastroenterol. 2014 Nov 14;20(42):15532-8. doi: 10.3748/wjg.v20.i42.15532.
9
Impact of recipient morbid obesity on outcomes after liver transplantation.受体病态肥胖对肝移植术后结局的影响。
Transpl Int. 2015 Feb;28(2):148-55. doi: 10.1111/tri.12483.
10
Living vs. deceased donor liver transplantation provides comparable recovery of renal function in patients with hepatorenal syndrome: a matched case-control study.活体与尸肝移植对肝肾综合征患者肾功能恢复的效果相当:一项匹配病例对照研究。
Am J Transplant. 2014 Dec;14(12):2788-95. doi: 10.1111/ajt.12975. Epub 2014 Oct 2.